FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Europe

Biotech startups that raised Series A in Europe

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Europe
One-time CSV
  • 488 funded companies, 327 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~europe.csv488 rows × 18 columns
CompanyCityLast roundAmountDate
BiolibertyEdinburghSeries A$3.3M2026-11-02
Cellbox SolutionsCologneSeries A$1.7M2026-10-20
BiolevateParisSeries A$34.4M2026-09-21
Matisse PharmaceuticalsGeleenSeries A$16.0M2026-09-17
Amyl TherapeuticsLiègeSeries A$9.6M2026-09-01
Adaptyv BiosystemsLausanneSeries A$40.0M2026-08-25
KynexisNaardenSeries A$112.3M2026-08-19
Alchemab TherapeuticsLondonSeries A$33.6M2026-07-09

8 rows of the CSV in 5 of its 18 columns.

488
Startups
$7.7B
Total raised
61
Funded in the last 12 months
$1.8B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 488
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh, United Kingdom Series A $3.3M 2026-11-02 $17.4M Innovate UK, Scottish Enterprise, Old College Capital +2 11 to 50 2020
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M European Innovation Council, Fraunhofer Venture, CK Venture Capital 11 to 50 2017
Biolevate Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. Artificial intelligence Paris, France Series A $34.4M 2026-09-21 $40.7M Bpifrance, EQT Ventures 11 to 50 2024
Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen, The Netherlands Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014
Amyl Therapeutics Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. Biotech Liège, Belgium Series A $9.6M 2026-09-01 $44.0M Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 1 to 10 2020
Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne, Switzerland Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden, The Netherlands Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London, United Kingdom Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
Apoha Apoha is a start-up that has not yet publicly launched. Biotech London, United Kingdom Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
mbiomics mbiomics is a biotechnology company. Biotech Munich, Germany Series A $12.0M 2026-04-28 $26.1M HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital 11 to 50 2020
Generare Generare discovers new medicines and valuable molecules from soil bacteria. Artificial intelligence Paris, France Series A $23.1M 2026-04-02 $32.2M Better Angle, Teampact ventures, Galion.exe +1 11 to 50 2022
Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Cambridge, United Kingdom Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
Kupando Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. Biotech Schönefeld, Germany Series A $11.5M 2026-03-18 $24.0M HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 1 to 10 2018
Bon Vivant Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. Biotech Lyon, France Series A $29.4M 2026-02-24 $59.6M Kima Ventures, Picus Capital, Sofinnova Partners +1 11 to 50 2021
KluraLabs KluraLabs manufactures products that use nanotechnology to inactivate viruses and bacteria. Biotech Haverhill, United Kingdom Series A $11.0M 2026-02-03 $11.0M Starship Ventures 11 to 50 2020
Biorce Biorce develops a clinical AI assistant that speeds up and lowers the cost of clinical trials. Artificial intelligence Barcelona, Spain Series A $52.0M 2026-02-02 $61.5M Plug and Play, YZR Capital, Outsized Ventures +1 11 to 50 2024
Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne, Switzerland Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
Octarine Bio Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. Biotech Copenhagen, Denmark Series A $5.9M 2026-01-22 $15.5M MassChallenge, Vaekstfonden, Unconventional Ventures +2 11 to 50 2018
Luminate Medical Luminate Medical develops a medical device that prevents hair loss during chemotherapy. Biotech Galway, Ireland Series A $21.0M 2026-01-07 $60.6M Y Combinator, Pareto Holdings, EIC Accelerator +1 11 to 50 2018
FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury, United Kingdom Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021
Bioxodes Bioxodes develops high value products derived from natural sources. Biotech Marche-en-famenne, Belgium Series A $6.4M 2025-12-10 $25.6M European Commission 11 to 50 2013
Pack Pack is an HR technology platform that supports employee growth through data-driven mentoring and coaching. Biotech Barcelona, Spain Series A $6.7M 2025-12-02 $8.0M Techstars, Invitalia, Praxi 11 to 50 2022
Qorium Qorium makes reinvented real leather materials. Biotech Maastricht, The Netherlands Series A $25.5M 2025-11-11 $28.6M Sofinnova Partners, Brightlands Venture Partners 11 to 50 2021
Adcytherix Adcytherix is a biopharmaceutical firm developing antibody drug conjugates. Biotech Marseille, France Series A $122.8M 2025-10-16 $155.1M RA Capital Management, Pureos Bioventures, Pontifax +1 11 to 50 2023
Genomines Genomines is a biotechnology company that uses plants for mining. Biotech Paris, France Series A $45.0M 2025-09-17 $61.8M Bpifrance, Elemental Impact, Lowercarbon Capital 11 to 50 2021
Comphya Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. Biotech Lausanne, Switzerland Series A $4.0M 2025-07-08 $14.2M Venture Kick, Verve Ventures, Nest Collective Foundation 1 to 10 2017
Adiposs Adiposs SA is a clinical-stage life science company developing a first-in-class imaging product for cancer patients. Biotech Geneva, Switzerland Series A $5.0M 2025-06-30 $7.4M MassChallenge, Venture Kick, FONGIT Innovation Fund +2 1 to 10 2020
Augustine Therapeutics Augustine Therapeutics discovers and develops medicines for neuromuscular and neurodegenerative diseases. Biotech Leuven, Belgium Series A $83.9M 2025-03-24 $106.8M PMV, V-Bio Ventures, VIB 11 to 50 2019

Table 1. Biotech startups that raised Series A in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 488.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden, The Netherlands Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
2 Biorce Biorce develops a clinical AI assistant that speeds up and lowers the cost of clinical trials. Artificial intelligence Barcelona, Spain Series A $52.0M 2026-02-02 $61.5M Plug and Play, YZR Capital, Outsized Ventures +1 11 to 50 2024
3 FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
4 Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne, Switzerland Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
5 Apoha Apoha is a start-up that has not yet publicly launched. Biotech London, United Kingdom Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
6 Biolevate Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. Artificial intelligence Paris, France Series A $34.4M 2026-09-21 $40.7M Bpifrance, EQT Ventures 11 to 50 2024
7 Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London, United Kingdom Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
8 EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury, United Kingdom Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021
9 Bon Vivant Bon Vivant uses precision fermentation to produce real dairy products accessible to everyone. Biotech Lyon, France Series A $29.4M 2026-02-24 $59.6M Kima Ventures, Picus Capital, Sofinnova Partners +1 11 to 50 2021
10 Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne, Switzerland Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021

Table 2. Biotech startups that raised Series A in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 22 5% 2 mbiomics, Kupando
2 Venture Kick Startup incubator Schlieren, Switzerland 10 2% 1 Adaptyv Biosystems
3 Bpifrance Government investment office Maisons-alfort, France 8 2% 1 Biolevate
4 Sofinnova Partners Venture capital firm Paris, France 7 1% 1 Bon Vivant
5 European Innovation Council Startup accelerator Brussels, Belgium 6 1% 1 Cellbox Solutions
6 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 6 1% 1 FoRx Therapeutics
7 KfW Government investment office Frankfurt, Germany 6 1%
8 Innovate UK Entrepreneurship program Swindon, United Kingdom 5 1% 3 Bioliberty, Apoha, Lucida Medical
9 Foundation for Innovation and Technology (FIT) Entrepreneurship program Lausanne, Switzerland 5 1% 1 Adaptyv Biosystems
10 Forbion Capital Partners Private equity firm Naarden, The Netherlands 5 1% 1 Kynexis
11 RA Capital Management Startup incubator Boston, United States 5 1% 1 Alchemab Therapeutics
12 Bayern Kapital Venture capital firm Landshut, Germany 5 1% 1 mbiomics
13 Y Combinator Startup accelerator Mountain View, United States 4 1% 2 Adaptyv Biosystems, Luminate Medical
14 EIC Accelerator Startup accelerator Brussels, Belgium 4 1% 1 Luminate Medical
15 Novartis Venture Fund Corporate venture arm Basel, Switzerland 4 1% 1 FoRx Therapeutics

Table 3. Biotech startups that raised Series A in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 373 76% $6.6B
Software 56 11% $596.5M
Artificial intelligence 29 6% $506.5M
Hardware 20 4% $105.7M
Education 5 1% $20.3M
Fintech 5 1% $28.3M
Energy 3 1%
Commerce 1 0% $11.0M
Cybersecurity 1 0%

Table 4. Biotech startups that raised Series A in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 488 100% $11.3M

Table 5. Biotech startups that raised Series A in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 125 26%
France 76 16%
Germany 58 12%
Switzerland 56 11%
The Netherlands 31 6%
Belgium 25 5%
Denmark 22 5%
Italy 16 3%
Spain 15 3%
Austria 15 3%
Sweden 12 2%
Ireland 9 2%

Table 6. Biotech startups that raised Series A in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 43 9%
Paris 31 6%
Cambridge 19 4%
Basel 13 3%
Oxford 11 2%
Copenhagen 11 2%
Lausanne 10 2%
Lyon 10 2%
Vienna 10 2%
Milan 7 1%
Barcelona 7 1%
Edinburgh 6 1%

Table 7. Biotech startups that raised Series A in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 3 5% $138.2M
October 2026 5 8% $49.3M
September 2026 10 16% $168.4M
August 2026 2 3% $152.3M
July 2026 4 7% $68.4M
June 2026 4 7% $274.0M
May 2026 2 3% $106.0M
April 2026 5 8% $200.6M
March 2026 5 8% $136.4M
February 2026 5 8% $139.5M
January 2026 7 11% $132.1M
December 2025 9 15% $277.2M

Table 8. Biotech startups that raised Series A in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 52 11% $1.6B
2025 52 11% $2.0B
2024 58 12% $1.3B
2023 45 9% $1.1B
2022 37 8% $731.6M
2021 45 9% $864.1M

Table 9. Biotech startups that raised Series A in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 21 4%
2020 to 2022 83 17%
2015 to 2019 183 38%
2010 to 2014 113 23%
Before 2010 84 17%

Table 10. Biotech startups that raised Series A in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 149 31%
11 to 50 290 61%
51 to 100 28 6%
101 to 250 7 1%
251 to 500 2 0%
501 to 1,000 2 0%

Table 11. Biotech startups that raised Series A in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Europe whose last round is Series A are on the list?
488, in the file dated 16 November 2026. 61 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 488 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Europe: 488 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Europe

Other sectors that raised Series A in Europe

Cite: FundingWatcher, 488 biotech companies in Europe whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/europe/